Researcher hopes to make gene-editing device safer and more precise

By: Jan Jarvis

Crispr Web

The mere mention of gene editing and DNA altering might conjure up images of designer babies, but that is not what researcher Jin Liu has in mind.

She wants help to find a cure for life-threatening diseases by making the gene-editing device CRISPR-Cas9 safer and more precise.

“Any genetic disease, the CRISPR-Cas9 technology has the potential to cure,” Dr. Liu said. “Cancer, eye diseases and sickle cell anemia for example.”

The CRISPR-Cas9 system allows researchers to make changes in a cell’s genetic code. The Cas9 enzyme is used to cut the DNA. But there is a problem standing in the way of successfully finding the cut position and altering the gene, said Dr. Liu, Assistant Professor of Pharmaceutical Sciences.

“When something is wrong with the DNA we can cut it out and repair it,” she said “But to bring the technology to the therapeutic field we have to be able to cut the DNA as accurately as possible.”

Finding a way to cut into the DNA with specificity is one of the goals that Dr. Liu wants to achieve with the help of a $437,864 National Institute of Health/National Heart Lung and Blood Institute grant.

When DNA is in the wrong place, it is called “off-target effects.”

“The goal is to reduce the off-target effects and increase the on-target effects,” she said. “You only want the DNA modification to be on-target.”

Using computer models to simulate how Cas9 enzyme interacts with DNA, Dr. Liu is working to better understand the mechanisms behind the off target effects.

“If we can figure that out, then we can understand the modifications that need to be made to eliminate undesirable results,” she said. “We can design a new enzyme that cuts DNA precisely.”

The next step is to test the approach in the lab to see if it performs as well as expected. Eye diseases will probably be the first model tested, Dr. Liu said. The technology could one day be used to cure lymphoma, HIV and sickle cell disease.

“There’s a lot of potential with this technology,” she said, “Many diseases could be cured.”

Recent News

M&c Prsa
  • Our People
|Nov 14, 2024

UNTHSC honored with two awards at PRSA Worthy Awards for Excellence in Communication

The University of North Texas Health Science Center at Fort Worth’s Office of Marketing and Communications received top honors at the recent PRSA Worthy Awards, winning awards for video production and print communication. The awards, presented by the Greater Fort Worth Chapter of the Public Re...
Dimitrios Karamichos
  • Community
|Nov 13, 2024

Karamichos named fellow of international vision research organization

Dr. Dimitrios Karamichos, interim dean of the College of Biomedical and Translational Sciences at The University of North Texas Health Science Center at Fort Worth has been named a 2025 Silver Fellow of the Association for Research in Vision and Ophthalmology.   Karamichos, who also serves ...
Dr. Cody Bruce
  • Our People
|Nov 13, 2024

Dr. Cody Bruce: A Legacy of Resilience and Care Rooted in Native American Heritage

Dr. Cody Bruce – a nursing associate professor at The University of North Texas Health Science Center at Fort Worth’s College of Nursing – attributes his roots in the Choctaw-Apache tribe of Ebarb, Louisiana, in shaping his path from clinical practice to academia. Bruce’s heritage has instil...
Robyn Remotigue 1 .august 2024
  • Community
|Nov 12, 2024

Robyn B. Remotigue honored with distinguished service award for pioneering leadership in research administration

Robyn B. Remotigue, executive director of the Office of Research and Scholarship at the College of Nursing at The University of North Texas Health Science Center at Fort Worth, was recently presented with the 2024 Distinguished Service Award from Region 5 (Texas/Okla.) of the National Council of Uni...